Nek2 siRNA therapy using a portal venous port-catheter system for liver metastasis in pancreatic cancer

DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA

(2012) Xiangyi He et al.   CARCINOGENESIS

AGR2 Is a Novel Surface Antigen That Promotes the Dissemination of Pancreatic Cancer Cells through Regulation of Cathepsins B and D

(2011) L. Dumartin et al.   CANCER RESEARCH

Novel combination treatment for colorectal cancer using Nek2 siRNA and cisplatin

(2010) Kazushi Suzuki et al.   CANCER SCIENCE

Efficient and targeted delivery of siRNA in vivo

(2010) Min Suk Shim et al.   FEBS Journal

Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras

(2010) Synne Wedén et al.   INTERNATIONAL JOURNAL OF CANCER

Retroviral delivery of RNA interference against Marek's disease virus in vivo

(2009) M. Chen et al.   POULTRY SCIENCE

Nek2 as a novel molecular target for the treatment of breast carcinoma

(2008) Nobuyuki Tsunoda et al.   CANCER SCIENCE

Pancreatic cancer: a generalized disease—prognostic impact of cancer cell dissemination

(2008) D. Bogoevski et al.   LANGENBECKS ARCHIVES OF SURGERY

Expression of shRNA From a Tissue-specific pol II Promoter Is an Effective and Safe RNAi Therapeutic

(2008) Jeffery C Giering et al.   MOLECULAR THERAPY